MAIN OUTCOMES OF VIRAL HEPATITIS B-RELATED ONCOGENICITY STUDY OVER THE PAST THIRTY YEARS
Abstract
The review is devoted to viral hepatitis B-related oncological aspects and reflects the most important outcomes of this infection 30-year study in oncological terms. The authors summarized the data demonstrating the existence of several hepatitis B virus (HBV)-related oncological aspects, in particular: the role of HBV infection in the occurrence of hepatocellular cancer and tumors of other histogenesis; HBV spread and course peculiarities in cancer patients; the significance of this infection in oncology practice; treatment tactics for cancer patients with HBV infection; drug therapy potentials for the management of the infection negative impact on the course of cancer.
References
World Health Organization. Prevention of liver cancer: report of a WHO meeting [held in Geneva from 30 Jan to 4 Feb 1983] [Internet]. Geneva; 1983. 34 p. (World Health Organization technical report series; no. 691). Available from: https://iris.who.int/handle/10665/39171.
Kuntz E, Kuntz H-D. Hepatology: principles and practice. History, Morphology, Biochemistry, Diagnostics, Clinic, Therapy. 2nd ed. Berlin: Springer-Verlag; 2006. Chap. 34, Chronic hepatitis; p. 691-714.
Sherlock S, Fix R, Niazi S, Scheur P. Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet. 1970;1(7659):1243-1247. https://doi.org/10.1016/s0140-6736(70)91737-x.
Aliev DA, Mamedov MK, Gudratov HO. Onkologicheskie aspekty virusnogo gepatita B. Mihajlov MI, ed. Baku: Bilik; 1993. 147 p. (Russian).
Bukrinskaja AG. Ob onkologicheskih aspektah transfuzionnyh virusnyh gepatitov. Azerbajdzhanskij zhurnal onkologii i smezhnyh nauk [Azerbaijan journal of oncology and related sciences]. 2002;9(1-2):112-113. (Russian).
Mamedov MK, Mihajlov MI. Transfuzionnye virusnye gepatity i onkologicheskie zabolevanija. Moscow: Kristall; 2008. 277 p. (Russian).
Mihajlov MI, Mamedov MK. Virusnye gepatity B i C u onkologicheskih bolnyh. Moscow: VK; 2012. 228 p. (Russian).
Gijasbejli SR. Infekcija, vyzvannaja virusom gepatita B: netradicionnye aspekty. Vita Med J. 2000;1:15-21. (Russian).
DeVita V, Hellman S, Rosenberg S, eds. Cancer: Principles and Practice of Oncology. 10th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins Publishers; 2015. Chap. 132, Infections in the cancer patients; p. 1931-1959.
Price P, Sikora K, eds. Treatment of cancer. 4th ed. London: Arnold; 2002. 1250 p.
Davydov MI, chief ed. Jenciklopedija klinicheskoj onkologii: osnovnye sredstva i metody diagnostiki i lechenija zlokachestvennyh novoobrazovanij. Moscow: OOO "RLS-2004"; 2004. Chap. 9, Virusnye infekcii u onkologicheskih bolnyh; p. 888-894. (Russian).
Zhukov HV. Virusnye infekcii. In: Davydov MI, Dmitrieva HV, eds. Infekcii v onkologii. Moscow: Prakticheskaja medicina; 2009. p. 115-124. (Russian).
Mamedov MK, Mikhailov MI. Hronicheskaja infekcija, vyzvannaja virusom gepatita B, kak faktor formirovanija priobretennoj predispozicii k nepechenochnym zlokachestvennym opuholjam [Chronic infection caused with hepatitis B virus as a forming factor of the acquired predysposition to extrahepatic malignant tumours]. Biomedicina [Biomedicine (Baku)]. 2021;19(4):4-13. https://doi.org/10.24412/1815-3917-2021-4-4-13. (Russian).
Mamedov MK, Mihajlov MI. O vozmozhnoj perspektivnosti rasshirenija masshtabov vakcinacii protiv virusnogo gepatia B s pozicii onkologii. Azerbajdzhanskij zhurnal onkologii i smezhnyh nauk [Azerbaijan journal of oncology and related sciences]. 2022;2:71-75. (Russian).
Mamedov MK, Mihajlov MK. Nositelstvo poverhnostnogo antigena virusa gepatita B kak odin iz neblagoprijatnyh prognosticheskih faktorov pri rake molochnoj zhelezy. Voprosy virusologii. 1992;37(1):71. (Russian).
Giyasbeyli SR, Zeinalov RS, Mamedov MK, Orujli RN, Mikhailov MI. Neposredstvennye rezultaty lechenija neoperabelnogo raka zheludka u bolnyh, inficirovannyh virusom gepatita B [Immediate results of inoperable stomach cancer treatment at patients infected with hepatitis B virus]. Azerbajdzhanskij zhurnal onkologii i smezhnyh nauk [Azerbaijan journal of oncology and related sciences]. 1999;5(1-2):28-31. (Russian).
Mamedov MK, Mihajlov MI. O vlijanii subklinicheskoj infekcii, vyzvannoj virusom gepatita B na neposredstvennye i otdalennye rezultaty lechenija bolnyh Hodzhkinskimi limfomami. Biomedicina [Biomedicine (Baku)]. 2005;4:38-39. (Russian).
Mamedov MK, Mihajlov MI, Zejnalov RS. Hronicheskaja infekcija, vyzvannaja virusom gepatita B, kak prediktor uhudshenija prognoza onkologicheskih zabolevanij. Sovremennye dostizhenija Azerbajdzhanskoj mediciny. 2019;3:28-32. (Russian).
Gijasbejli SR, Mamedov MK. Hronicheskaja infekcija, vyzvannaja virusom gepatita B, kak prediktor uhudshenija prognoza onkologicheskih zabolevanij. Sovremennye dostizhenija Azerbajdzhanskoj mediciny. 2008;3:199-202. (Russian).
Mamedov MK, Mikhaylov MI. Ocenka onkologicheskih aspektov v izuchenii virusnogo gepatita C [Assessment of oncological aspects in viral hepatitis C studying]. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2019;8(2):59-63. https://doi.org/10.24411/2305-3496-2019-12008. (Russian).
